Vector AIS, the modern fund administrator purpose-built for closed-end alternative investment funds, is excited to announce ...

Adenoviruses as gene-delivery vectors took a hit 20 years ago ... With their 2022 start-up Vector Biopharma, Andreas Plückthun of the University of Zurich and serial pharmaceutical executive ...

These viruses can also trigger dangerous immune responses. Vector BioPharma is taking a different approach with a delivery vehicle that’s like a virus, but devoid of the features that limit ...

airway clearance has been used in AAV clinical trials to increase vector delivery to the lung. Eight-week old IL-10-deficient transgenic (IL-10T) mice (C57BL/6 background) were purchased from the ...

The campus will also house a research institution dedicated to developing new gene delivery techniques, vector-based vaccines, virus-based cancer therapeutics, and training for scientists and ...